Back to 
Parallax Volatility Advisers, L.P.
Parallax Volatility Advisers, L.P.
IBRX
2 quarters
Position history for Parallax Volatility Advisers, L.P.'s holdings in ImmunityBio, Inc.
No. Parallax Volatility Advisers exited its IBRX (ImmunityBio) position in Q3 2023. Its Q2 2023 13F listed 297 shares worth $826. Parallax Volatility Advisers first reported IBRX in Q2 2023 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$826
Total Shares Change
-297
Quarter-by-Quarter History
Other major holders of IBRX: BlackRock, Inc., State Street Corp., Vanguard Portfolio Management LLC, Vanguard Capital Management LLC